{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:41:22Z","timestamp":1778658082653,"version":"3.51.4"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.braindev.2020.12.018","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T01:01:56Z","timestamp":1610931716000},"page":"666-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Low-dose phenobarbital for epilepsy with myoclonic absences: A case report"],"prefix":"10.1016","volume":"43","author":[{"given":"Susumu","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoruko","family":"Nagumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Oguni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.12.018_b0005","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389\u201399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"issue":"3","key":"10.1016\/j.braindev.2020.12.018_b0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.braindev.2004.01.008","article-title":"Epilepsy with myoclonic absences","volume":"27","author":"Bureau","year":"2005","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2020.12.018_b0015","series-title":"Epileptic syndromes in infancy, childhood and adolescence","first-page":"297","article-title":"Myoclonic absences and absences with myoclonias","author":"Bureau","year":"2012"},{"key":"10.1016\/j.braindev.2020.12.018_b0020","unstructured":"National Institute for Health and Care Excellence. Epilepsies: diagnosis and management. Clinical guideline [CG137]. 2012, updated 2020. www.nice.org.uk\/guidance\/cg137."},{"issue":"3","key":"10.1016\/j.braindev.2020.12.018_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/epi4.12339","article-title":"De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences","volume":"4","author":"Hiraide","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.braindev.2020.12.018_b0030","doi-asserted-by":"crossref","first-page":"106452","DOI":"10.1016\/j.eplepsyres.2020.106452","article-title":"Inhibitory effect of anti-seizure medications on ionotropic glutamate receptors: special focus on AMPA receptor subunits","volume":"167","author":"Fukushima","year":"2020","journal-title":"Epilepsy Res"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420303533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420303533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:49:05Z","timestamp":1759952945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420303533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0387760420303533"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.12.018","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose phenobarbital for epilepsy with myoclonic absences: A case report","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Japanese Society of Child Neurology Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}